Globally, 290 million people are unaware they are living with a hepatitis C virus (HCV) infection. This significant global health problem affects as many as 80,000 individuals here in BC. Today on World Hepatitis Day, the theme is ‘Find the Missing Millions’ in order to raise awareness of the global burden of viral hepatitis and to influence real change.
The BC-CfE’s Per-SVR Team Fights for HCV Awareness Read More »
The 29th Annual Canadian Conference on HIV/AIDS Research (CAHR 2020) will be going virtual this year. Click Virtual Conference Program in the menu bar for more information. Register now to ensure you receive access to the Conference. Registration is complimentary.
BC-CfE Research Presented at the CAHR 2020 Virtual Conference Read More »
The fall HIV/ARV Update brought expert presentations about scientific findings on HIV decriminalization, phylogenetics, Indigenous health and more.
HIV decriminalization, phylogenetics and Indigenous health headline Fall ARV update Read More »
Doctors at an addiction-management clinic in Vancouver have been asking patients a new question when they come in to refill their methadone prescriptions: Do they want to get tested for hepatitis C? They perform a quick finger-prick test for those who say yes during their regular visit to Vancouver’s Royal Oak Clinic – part of
B.C. steps up fight against hepatitis C with more tests for higher-risk populations Read More »
Fifty-three year old Vancouver resident Sage Rinaldo lived with hepatitis C for many years before working up the courage to seek treatment. Rinaldo credits a community health nurse in the Downtown Eastside who gained her trust and helped her successfully treat her hepatitis C with a new anti-viral treatment. Now, Rinaldo is giving back by taking part in a long-term follow up study focussed on reinfection prevention. The Per-SVR study is aiming to better understand if, how and when hepatitis C reinfection may occur.
Power combo: Harm reduction plus effective treatment help prevent spread of Hepatitis C Read More »
On June 26th, BC Health Minister Adrian Dix joined BC-CfE Director Dr. Julio Montaner to mark very encouraging progress on the uptake of HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) in BC, since the January 1st launch of the publicly funded program. At the press event, which took place at Jim Deva Plaza in
BC Minister of Health announces swift progress on PrEP program Read More »
The new wave is here. Now that effective hepatitis C treatments are available, there is a global movement to end hepatitis C with surging political will.
Per-SVR research study aims to help curb hep C reinfection Read More »
Most people infected with Hep C do not experience any symptoms for decades. For those that do, the symptoms are often mild and flu-like, for example, feeing very tired, sore muscles, fever and nausea. These symptoms usually occur within 2 weeks to 6 months of exposure.
The BC Centre for Excellence (BC-CfE) is excited to launch an art contest to mark World Hepatitis Day on July 28th 2017. With this contest we hope to raise awareness about hepatitis C virus (HCV).
In Canada, it is estimated that 300,000 people are living with HCV with approximately 80,000 of those living in BC. HCV is passed on when the blood from someone who has HCV gets into the bloodstream of another person. This can happen with high risk sexual practices; sharing injection equipment or getting a tattoo or piercing with unsterilized equipment.
World Hepatitis Day Art Contest Read More »
Some of the province’s most vulnerable people will benefit from research into HIV/AIDS, addiction and viral hepatitis that will be carried out at the world-class Hope to Health Research Centre following a successful expansion project supported in part through $2 million in government funding. |
Government funding helps Hope to Health Grow Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
